Skip to main content

Additional Potential Therapeutic Applications for Rice Bran Arabinoxylan Compound

  • Chapter
  • First Online:
Modified Rice Bran Arabinoxylan

Abstract

This chapter highlights the research literature on using rice bran arabinoxylan compound (RBAC) as a nutraceutical and functional food for a range of acute and chronic conditions. RBAC has shown potential for supporting the liver, particularly in fatty liver disease, which involves an accumulation of fat in the parenchymal cells of the liver. Chronic fatigue syndrome (CFS) is a persistent relapsing fatigue not alleviated by rest and exacerbated by moderate exercise. Research suggests that RBAC may support persons with CFS. Common colds and influenza are the most common diseases in humans. Studies on RBAC show beneficial effects in reducing the physical stress associated with acute respiratory tract infections and reveals prophylactic effects. Diabetes mellitus (DM) is a group of disorders characterised by hyperglycaemia resulting from insulin resistance, inadequate insulin secretion, or excessive glucagon secretion. In animal-based studies, RBAC reveals therapeutic potential for DM through multiple pathways. Irritable bowel syndrome (IBS) involves a disordered communication between the gut and brain, resulting in disturbances in motility, visceral hypersensitivity, and altered central nervous system processing. Previous research indicates that the administration of RBAC improves IBS symptoms, which may be associated with the compound’s anti-inflammatory and immune-modulatory effects. Rheumatoid arthritis (RA) is a progressive inflammatory autoimmune disease associated with articular and systemic effects. Case studies of RBAC administration in chronic rheumatism have shown improvements in pain, quality of life, and serological assessments. Although the available evidence indicates the therapeutic benefits of RBAC in these disorders, further research is required to explain the mechanisms for altering the pathophysiology of the disease pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Afari N, Buchwald D (2003) Chronic fatigue syndrome: a review. Am J Psychiatry 160:221–236

    Google Scholar 

  • Alam U, Asghar O, Azmi S, Malik RA (2014) General aspects of diabetes mellitus. Handb Clin Neurol 126:211–222

    Google Scholar 

  • Alauddin M, Shirakawa H, Koseki T, Kijima N, Ardiansyah, Budijanto S et al (2016) Fermented rice bran supplementation mitigates metabolic syndrome in stroke-prone spontaneously hypertensive rats. BMC Complement Altern Med 16:442

    Google Scholar 

  • Antunes C, Azadfard M, Hoilat GJ, Gupta M (2021) Fatty liver. In: StatPearls [internet]. StatPearls Publishing, Treasure Island, FL. https://www.ncbi.nlm.nih.gov/books/NBK441992/

    Google Scholar 

  • Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D et al (2004) Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126:693–702

    Google Scholar 

  • Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28:155–161

    Google Scholar 

  • Blair M (2016) Diabetes mellitus review. Urol Nurs 36:27–36

    Google Scholar 

  • Bruta K, Vanshika, Bhasin K, Bhawana (2021) The role of serotonin and diet in the prevalence of irritable bowel syndrome: a systematic review. Transl Med Commun 6:1

    Google Scholar 

  • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023

    Google Scholar 

  • Cho HJ, Skowera A, Cleare A, Wessely S (2006) Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology. Curr Opin Psychiatry 19:67–73

    Google Scholar 

  • Choy E (2012) Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 51:v3–v11

    CAS  Google Scholar 

  • Eccles R (2005) Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5:718–725

    Google Scholar 

  • Elsaid AF, Fahmi RM, Shaheen M, Ghoneum M (2020) The enhancing effects of Biobran/MGN-3, an arabinoxylan rice bran, on healthy old adults’ health-related quality of life: a randomized, double-blind, placebo-controlled clinical trial. Qual Life Res 29:357

    CAS  Google Scholar 

  • Elsaid AF, Agrawal S, Agrawal A, Ghoneum M (2021) Dietary supplementation with Biobran/MGN-3 increases innate resistance and reduces the incidence of influenza-like illnesses in elderly subjects: a randomized, double-blind, placebo-controlled pilot clinical trial. Nutrients 13:4133

    CAS  Google Scholar 

  • Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A et al (2011) The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 7:313–324

    CAS  Google Scholar 

  • Ford AC, Sperber AD, Corsetti M, Camilleri M (2020) Irritable bowel syndrome. Lancet 396:1675–1688

    CAS  Google Scholar 

  • Fu J, Nogueira SV, van Drongelen V, Coit P, Ling S, Rosloniec EF et al (2018) Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis. Proc Natl Acad Sci U S A 115:4755–4760

    CAS  Google Scholar 

  • Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121:953–959

    CAS  Google Scholar 

  • Gruver AL, Hudson LL, Sempowski GD (2007) Immunosenescence of ageing. J Pathol 211:144–156

    CAS  Google Scholar 

  • Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA (2015) Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes 6:598–612

    Google Scholar 

  • Heikkinen T, Järvinen A (2003) The common cold. Lancet 361:51–59

    Google Scholar 

  • Hickie I, Koschera A, Hadzi-Pavlovic D, Bennett B, Lloyd A (1999) The temporal stability and co-morbidity of prolonged fatigue: a longitudinal study in primary care. Psychol Med 29:855–861

    CAS  Google Scholar 

  • Ichihashi K (2004) Experience with administration of BioBran in patients with chronic rheumatism. Clin Pharmacol Ther 14:459–463

    Google Scholar 

  • Jackson GG, Dowling HF, Spiesman IG, Boand AV (1958) Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med 101:267–278

    CAS  Google Scholar 

  • Johnston S, Brenu EW, Staines D, Marshall-Gradisnik S (2013) The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis. Clin Epidemiol 5:105–110

    Google Scholar 

  • Jordan KM, Landis DA, Downey MC, Osterman SL, Thurm AE, Jason LA (1998) Chronic fatigue syndrome in children and adolescents: a review. J Adolesc Health 22:4–18

    CAS  Google Scholar 

  • Kamiya T, Shikano M, Tanaka M, Ozeki K, Ebi M, Katano T et al (2014) Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study. Evid Based Complement Alternat Med 2014:828137

    Google Scholar 

  • Kenyon J (2001) A descriptive questionnaire-based study on the use of Biobran (MGN3), in chronic fatigue syndrome. Townsend Lett Dr Patients 220:48–50

    Google Scholar 

  • Krupp LB, Mendelson WB, Friedman R (1991) An overview of chronic fatigue syndrome. J Clin Psychiatry 52:403–410

    CAS  Google Scholar 

  • Laue C, Stevens Y, van Erp M, Papazova E, Soeth E, Pannenbeckers A et al (2021) Adjuvant effect of orally applied preparations containing non-digestible polysaccharides on influenza vaccination in healthy seniors: a double-blind, randomised, controlled pilot trial. Nutrients 13:2683

    CAS  Google Scholar 

  • Lewis JE, Atlas SE, Higuera OL, Fiallo A, Rasul A, Farooqi A et al (2018) The effect of a hydrolyzed polysaccharide dietary supplement on biomarkers in adults with nonalcoholic fatty liver disease. Evid Based Complement Alternat Med 2018:1751583

    Google Scholar 

  • Lombardi R, Onali S, Thorburn D, Davidson BR, Gurusamy KS, Tsochatzis E (2017) Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. Cochrane Database Syst Rev 3:CD011640

    Google Scholar 

  • Maeda H, Ichihashi K, Fujii T, Omura K, Zhu X, Anazawa M et al (2004) Oral administration of hydrolyzed rice bran prevents the common cold syndrome in the elderly based on its immunomodulatory action. Biofactors 21:185–187

    CAS  Google Scholar 

  • McDermott C, Richards SCM, Thomas PW, Montgomery J, Lewith G (2006) A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome. QJM 99:461–468

    CAS  Google Scholar 

  • McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219

    CAS  Google Scholar 

  • Mendez-Encinas MA, Carvajal-Millan E, Rascon-Chu A, Astiazaran-Garcia HF, Valencia-Rivera DE (2018) Ferulated arabinoxylans and their gels: functional properties and potential application as antioxidant and anticancer agent. Oxid Med Cell Longev 2018:22

    Google Scholar 

  • Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J (2000) Clinical signs and symptoms predicting influenza infection. Arch Intern Med 160:3243–3247

    CAS  Google Scholar 

  • Ohara I, Tabuchi R, Onai K, Econ MH (2000) Effects of modified rice bran on serum lipids and taste preference in streptozotocin-induced diabetic rats. Nutr Res 20:59–68

    CAS  Google Scholar 

  • Ohara I, Onai K, Maeda H (2002) Modified rice bran improves glucose tolerance in NIDDM adult rats given streptozotocin as neonates. Stud Aichi Gakusen Univ 37:17–23

    Google Scholar 

  • Ooi SL, Pak SC, Micalos PS, Schupfer E, Lockley C, Park MH et al (2021) The health-promoting properties and clinical applications of rice bran arabinoxylan modified with shiitake mushroom enzyme—a narrative review. Molecules 26:2539

    CAS  Google Scholar 

  • Parnell JA, Raman M, Rioux KP, Reimer RA (2012) The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int 32:701–711

    CAS  Google Scholar 

  • Pérez-Martínez A, Valentín J, Fernández L, Hernández-Jiménez E, López-Collazo E, Zerbes P et al (2015) Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo. Cytotherapy 17:601–612

    Google Scholar 

  • Petrovics G, Szigeti G, Hamvas S, Máté Á, Betlehem J, Hegyi G (2016) Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3-Arabinoxylane) and targeted radiofrequency heat therapy. Eur J Integr Med 8:29–35

    Google Scholar 

  • Rachana, Thakur S, Basu S (2015) Oxidative stress and diabetes. In: Rani V, Yadav UCS (eds) Free radicals in human health & diseases. Springer, New Delhi, pp 241–257

    Google Scholar 

  • Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313:2263–2273

    CAS  Google Scholar 

  • Saji N, Francis N, Schwarz LJ, Blanchard CL, Santhakumar AB (2019) Rice bran derived bioactive compounds modulate risk factors of cardiovascular disease and type 2 diabetes mellitus: an updated review. Nutrients 11:2736

    CAS  Google Scholar 

  • Schupfer E, Pak SC, Wang S, Micalos PS, Jeffries T, Ooi SL et al (2021) The effects and benefits of arabinoxylans on human gut microbiota – a narrative review. Food Biosci 43:101267

    CAS  Google Scholar 

  • Schwartz JM, Reinus JF (2012) Prevalence and natural history of alcoholic liver disease. Clin Liver Dis 16:659–666

    Google Scholar 

  • Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P (2007) New therapies for treatment of rheumatoid arthritis. Lancet 370:1861–1874

    CAS  Google Scholar 

  • Talley NJ, Holtmann G, Walker MM (2015) Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol 50:601–613

    CAS  Google Scholar 

  • Toshikuni N, Tsutsumi M, Arisawa T (2014) Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol 20:8393–8406

    Google Scholar 

  • Winther B, Gwaltney JMJ, Mygind N, Turner RB, Hendley JO (1986) Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 256:1763–1767

    CAS  Google Scholar 

  • Zambon MC, Stockton JD, Clewley JP, Fleming DM (2001) Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 358:1410–1416

    CAS  Google Scholar 

  • Zheng S, Sugita S, Hirai S, Egashira Y (2012) Protective effect of low molecular fraction of MGN-3, a modified arabinoxylan from rice bran, on acute liver injury by inhibition of NF-κB and JNK/MAPK expression. Int Immunopharmacol 14:764–769

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sok Cheon Pak .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Micalos, P.S., Pak, S.C., Ooi, S.L. (2023). Additional Potential Therapeutic Applications for Rice Bran Arabinoxylan Compound. In: Pak, S.C., Ooi, S.L., Micalos, P.S., Ghoneum, M.H. (eds) Modified Rice Bran Arabinoxylan . Springer, Singapore. https://doi.org/10.1007/978-981-19-5735-2_12

Download citation

Publish with us

Policies and ethics